ABBOTT INDIA LIMITED

🇮🇳India

Country: 🇮🇳India

Ownership: Private

Established: 1888-01-01

Employees: 73K

Market Cap: $7.5B

Website: http://www.abbott.com

Clinical Trials

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

Phase 3

Completed

Conditions: Leiomyoma
Menorrhagia
Metrorrhagia

Interventions: Drug: Asoprisnil

First Posted Date: 2005-09-12

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 523

Registration Number: NCT00156195

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Phase 3

Completed

Conditions: Leiomyoma
Menorrhagia
Metrorrhagia

Interventions: Drug: Asoprisnil
Drug: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 432

Registration Number: NCT00160381

Study of Asoprisnil in the Treatment of Uterine Fibroids.

Phase 3

Completed

Conditions: Fibroid Uterus
Leiomyoma
Menorrhagia
Metrorrhagia
Uterine Fibroids

Interventions: Drug: Asoprisnil

First Posted Date: 2005-09-12

Last Posted Date: 2008-05-28

Lead Sponsor: Abbott

Target Recruit Count: 149

Registration Number: NCT00156156

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

Phase 2

Completed

Conditions: Endometriosis

Interventions: Drug: Placebo
Drug: Asoprisnil

First Posted Date: 2005-09-12

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 131

Registration Number: NCT00160433

Treatment of Uterine Fibroids With Asoprisnil(J867)

Phase 3

Completed

Conditions: Menorrhagia
Leiomyoma
Metrorrhagia

Interventions: Drug: Asoprisnil
Drug: Placebo

First Posted Date: 2005-09-09

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 475

Registration Number: NCT00152269

A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women

Phase 2

Completed

Conditions: Postmenopause

Interventions: Drug: Asoprisnil/Premarin

First Posted Date: 2005-09-09

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 18

Registration Number: NCT00152295

A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

Phase 2

Completed

Conditions: Amenorrhea
Postmenopause

Interventions: Drug: Asoprisnil/Premarin
Drug: Placebo and Premarin

First Posted Date: 2005-09-09

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 105

Registration Number: NCT00152282

A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

Phase 3

Completed

Conditions: Fibroid Uterus
Leiomyoma
Menorrhagia
Metrorrhagia
Uterine Fibroids

Interventions: Drug: Placebo
Drug: Asoprisnil

First Posted Date: 2005-09-09

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 239

Registration Number: NCT00152256

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Phase 2

Completed

Conditions: Uterine Fibroids
Leiomyoma

Interventions: Drug: Placebo
Drug: Asoprisnil

First Posted Date: 2005-09-08

Last Posted Date: 2008-05-29

Lead Sponsor: Abbott

Target Recruit Count: 33

Registration Number: NCT00150644

A Long Term Safety Study With Atrasentan

Phase 2

Completed

Conditions: Prostate Cancer
Adenocarcinoma

First Posted Date: 2005-08-08

Last Posted Date: 2007-11-29

Lead Sponsor: Abbott

Target Recruit Count: 166

Registration Number: NCT00127478

Locations: 🇺🇸
University of Pittsburgh Department of Urology, Pittsburgh, Pennsylvania, United States
🇺🇸
South Florida Medical Research, Aventura, Florida, United States
🇺🇸
Prostate Oncology Specialists, Marina Del Rey, California, United States

and more 12 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy